adamantane has been researched along with Skin Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Yu, H; Zhou, J | 1 |
Baek, HS; Jang, WH; Joo, YH; Jung, K; Lee, CS; Lim, KM; Park, M; Park, YH | 1 |
2 other study(ies) available for adamantane and Skin Neoplasms
Article | Year |
---|---|
Targeting sphingosine kinase 2 by ABC294640 inhibits human skin squamous cell carcinoma cell growth.
Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice, Nude; Molecular Targeted Therapy; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Skin Neoplasms | 2018 |
A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKA-CREB-activated microphthalmia-associated transcription factor and tyrosinase expression.
Topics: Adamantane; Animals; Benzamides; Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation; Humans; Hyperpigmentation; Melanins; Melanocytes; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Signal Transduction; Skin; Skin Neoplasms | 2013 |